Avedro
The patented cross-linking procedure by Avedro is the first and only therapy approved by Food and Drug Administration of the United States that strengthens the cornea and slows the progression of keratoconus
-
What is keratoconus?
-
What are the symptoms?
-
What are the therapies?
<
>
Keratoconus is a condition in which the normal spherical shape of the cornea becomes thinner and weakens progressively causing a cone-shaped deformation.
This deformation can cause severe worsening of vision and in more advanced cases the progressive thinning of the cornea may make corneal transplantation necessary.
|
Keratoconus is a rare disease, typically diagnosed around the age of twenty and can progress for ten or twenty years before slowing down or stabilizing.
Keratoconus is always bilateral but the two eyes can be affected differently.
The main symptoms are:
Blurry vision
Distorted view
Increased light sensitivity
Keratoconus is always bilateral but the two eyes can be affected differently.
The main symptoms are:
Blurry vision
Distorted view
Increased light sensitivity
Keratoconus therapies correct the distorted vision caused by corneal deformation and reinforce or repair its structure.
Currently the options are:
Glasses
Rigid contact lenses
Corneal implants
Corneal cross-linking
Corneal transplant
Currently the options are:
Glasses
Rigid contact lenses
Corneal implants
Corneal cross-linking
Corneal transplant
-
What is cross-linking?
-
How does it work?
-
What next?
-
What about side effects?
<
>
Corneal cross-linking is a minimally invasive procedure that combines the use of eye drops with Vitamin B2 and an ultraviolet system to stop the progression of keratoconus.
Create new cross-links between the collagen fibers that make up the cornea The fibrils get shorter and thicker The cornea becomes more rigid and more solid |
The ophthalmologist will apply some eye drops that will be left to rest for about 10 minutes.
Afterwards the eye will be exposed to ultraviolet rays for 10 minutes and the treatment is complete.
Avoid rubbing your eyes for five days after the procedure.
You may notice discomfort in the light and a foreign body sensation, using sunglasses will help you feel better.
You could wear protective contact lenses
You may notice discomfort in the light and a foreign body sensation, using sunglasses will help you feel better.
You could wear protective contact lenses
Following treatment with Avedro KXL it is very important that you follow your doctor's instructions and that you present yourself punctually at check-ups to avoid unpleasant complications.
In April 2016, the US FDA approved Photrexa® Viscous, Photrexa® and the KXL® corneal cross-linking system, a minimally invasive procedure that combines the use of eye drops with Vitamin B2 and ultra-violet light (UV) At the moment Avedro is the only keratoconus therapy to have obtained this important certification |
I want to receive more information about KXL
|
KXL is produced by the American company leader in cross-linking Avedro.
https://avedro.com/ |